SECTIONS
SUBSCRIBE
Managed Care
Search form
  • News
  • Payers
  • Politics & policy
  • Drug management
  • Current Issue
  • Lung Cancer Screening
  • More
    • Past issues
    • Contact Us
    • Providers
    • Value-Based Care
    • Viewpoints
    • Original research
    • Profiles
    • Conversations
    • Legislation & regulation
    • Pharm D Corner
    • Tomorrow's Medicine
    • Contributing Voices

Most Popular

Why blockchain for health care may be finally turning the corner

Because it enables both the security and sharing of data, blockchain seems ideally suited to health care. Next year, the pieces may come together for it to finally get some real traction in the sector.

Read more

Antiviral drugs have made hepatitis C eminently treatable

The caveat: The prices are now falling for various reasons, but the high cost still means many who might benefit don’t have access to the medications.

Read more

HIV/AIDS treatment drastically reduces mortality and helps to limit transmission

The caveats: About 40,000 Americans are newly infected every year. And HIV infection is still among the top 10 leading causes of death among Americans between the ages of 25 and 44.

Read more

Insurers on a Shopping Spree For All Sorts of Providers

Vertical integration may make sense in the era of value-based care. But will the combinations limit patient choice–and pass antitrust muster?

Read more

Why vertical mergers will continue to dominate health care

Insurers are busy merging with retailers and providers in vertical integration deals after attempts at horizontal combinations hit antitrust roadblocks.

Read more

Cigna Buys Express Scripts

Cigna wasted little time trying to calm any fears that the deal could be harmful to patients in the long run. It loaded the first paragraph of its press release on the purchase with an announcement that it plans to donate $200 million to local charities and communities across the nation. In addition,…
Read more

FDA’s Gottlieb Aims To End Biosimilars Groundhog Day

The FDA commissioner has an 11-step ‘action plan’ to get biosimilars out of a repeat mode of unrealized potential. But issues like interchangeability still need clarifying if biosimilars are to have a major effect on drug expenditures.

Read more

Community health workers improve outcomes, reduce costs

Community health workers liaise between underserved populations and clinicians, help patients and resources to manage disease, and provide health education, informal counseling, and social support. Interest in community health workers is shifting away from narrowly focused intervention on a single disease toward care coordination of multiple chronic conditions.

Read more

Why bundled payments are poised to take off

BPCI Advanced signals a willingness among Medicare providers to redesign care and take on risk. Commercial payers are watching closely.

Read more

A Conversation with Gary Lyman, MD: Biosimilars and the Search for the Cure To Cancer Treatment’s Financial Toxicity

The price of biologics can ruin cancer patients financially, this leading oncology expert reminds us. Biosimilars may help, but we need more of them on the market.

Read more

Bundled payments for joint replacement reduce expenditures, don’t compromise quality

The caveat: Joint replacements might be a sweet spot for bundled payments. They might not work as well for other episodes of care.

Read more

Palliative care improves quality of life and symptoms

The caveats: It is difficult to study. The strongest evidence is for palliative care in hospitals.

Read more

Nurse practitioners provide quality primary care at a lower cost than physicians

The caveats: Most of the evidence involves routine care. It is uncertain whether nurse practitioners will be willing to work in rural areas to fill the primary care void.

Read more

Bringing Humira (Its Price) Down a Peg

The TNF-α blocker is the world’s top-selling drug, by revenue. It faces biosimilar competition in Europe, but it will be four years before it’s challenged in the U.S.

Read more

Why Medicare Advantage enrollment will keep on growing, whatever the politics

CMS has broadened the services that Medicare Advantage plans can provide—services that may reduce expensive treatments and injuries. Insurers continue to see the market as a business opportunity. Critics see a slow-motion privatization of Medicare.

Read more
Facebook Twitter LinkedIn RSS Feed
  • Contact Us
  • Our History
  • Terms & Conditions of Use Agreement
  • Address and Subscription Changes
  • Managed Care News Archive
  • 2019 Editorial Calendar
  • 2019 Media Kit
  • 2018 Media Kit
  • 2019 Space and Material Due Dates
  • BPA Statement
  • Editor’s Desk
  • Submitting Original Research
  • Submitting Viewpoints
  • Contact Webmaster
  • P&T Community
© 2019 MediMedia, an ICON plc company. All rights reserved.